Continuation of Research and Development Activities
First written in FY2017-Q1. 33 of 34 entries say "Restated". Latest entry: FY2027-H1.
97 other companies' latest entry also says "Restated".
- FY2027-H1RestatedAnnual report
「The amount spent on R&D activities during the interim consolidated accounting period was ¥193.640 million. There were no significant changes in the status of the Group's R&D activities during the interim consolidated accounting period.」
¥193.640 million was recorded as R&D expenses, with no significant changes in the status of R&D activities. - FY2026-H1RestatedAnnual report
「The amount spent on R&D activities during the interim consolidated accounting period was ¥200.914 million. There were no significant changes in the status of the Group's R&D activities during the interim consolidated accounting period.」
R&D activities are continuing, with ¥200.914 million recorded as R&D expenses. There have been no significant changes in the status of these activities. - FY2025-H1RestatedAnnual report
「The amount spent on R&D activities during the interim consolidated accounting period was ¥193.823 million. There were no significant changes in the status of the Group's R&D activities during the interim consolidated accounting period.」
R&D activities are continuing, with ¥193.823 million recorded as R&D expenses. There have been no significant changes in the status of these activities. - FY2025-Q1RestatedAnnual report
「The amount spent on R&D activities during the cumulative first quarter was ¥86.458 million. There were no significant changes in the status of the Group's R&D activities during the cumulative first quarter.」
¥86.458 million was recorded as R&D expenses, with no significant changes in the status of R&D activities. - FY2024RestatedAnnual report
「The Group's basic policy is to put customers first. To respond to the rapidly changing market environment, it appropriately anticipates consumer needs and works to develop higher-value-added products and improve quality. R&D expenses for the Western-Style Confectionery Manufacturing and Sales Business for the consolidated fiscal year were ¥386.621 million.」
The Group is continuing product development and quality improvement based on customer needs, and R&D activities, with ¥386.621 million recorded as R&D expenses. - FY2024-Q3RestatedAnnual report
「The amount spent on R&D activities during the cumulative third quarter was ¥287.036 million. There were no significant changes in the status of the Group's R&D activities during the cumulative third quarter.」
¥287.036 million was recorded as R&D expenses, with no significant changes in the status of R&D activities. - FY2024-Q2RestatedAnnual report
「The amount spent on R&D activities during the cumulative second quarter was ¥200.091 million. There were no significant changes in the status of the Group's R&D activities during the cumulative second quarter.」
¥200.091 million was recorded as R&D expenses, with no significant changes in the status of R&D activities. - FY2024-Q1RestatedAnnual report
「The amount spent on R&D activities during the cumulative first quarter was ¥87.519 million. There were no significant changes in the status of the Group's R&D activities during the cumulative first quarter.」
¥87.519 million was recorded as R&D expenses, with no significant changes in the status of R&D activities. - FY2023RestatedAnnual report
「The Group's basic policy is to put customers first. To respond to the rapidly changing market environment, it appropriately anticipates consumer needs and works to develop higher-value-added products and improve quality. R&D expenses for the Western-Style Confectionery Manufacturing and Sales Business for the consolidated fiscal year were ¥358.711 million.」
The Group is continuing product development and quality improvement based on customer needs, and R&D activities, with ¥358.711 million recorded as R&D expenses. - FY2023-Q3RestatedAnnual report
「The amount spent on R&D activities during the cumulative third quarter was ¥267.898 million. There were no significant changes in the status of the Group's R&D activities during the cumulative third quarter.」
¥267.898 million was recorded as R&D expenses, with no significant changes in the status of R&D activities. - FY2023-Q2RestatedAnnual report
「The amount spent on R&D activities during the cumulative second quarter was ¥185.224 million. There were no significant changes in the status of the Group's R&D activities during the cumulative second quarter.」
¥185.224 million was recorded as R&D expenses, with no significant changes in the status of R&D activities. - FY2022RestatedAnnual report
「The Company's basic policy is to put customers first. To respond to the rapidly changing market environment, it appropriately anticipates consumer needs and works to develop higher-value-added products and improve quality. R&D expenses for the Western-Style Confectionery Manufacturing and Sales Business for the fiscal year were ¥378.061 million.」
The disclosure covers product development and quality improvement based on customer needs, as well as R&D expenses of ¥378.061 million, reaffirming the continuation of R&D activities. - FY2022-Q3RestatedAnnual report
「The amount spent on R&D activities during the cumulative third quarter was ¥288.772 million. There were no significant changes in the status of the Company's R&D activities during the cumulative third quarter.」
¥288.772 million was recorded as R&D expenses, with no significant changes in the status of R&D activities. - FY2022-Q2RestatedAnnual report
「The amount spent on R&D activities during the cumulative second quarter was ¥197.098 million. There were no significant changes in the status of the Company's R&D activities during the cumulative second quarter.」
¥197.098 million was recorded as R&D expenses, with no significant changes in the status of R&D activities. - FY2022-Q1RestatedAnnual report
「The amount spent on R&D activities during the cumulative first quarter was ¥84.674 million. There were no significant changes in the status of the Company's R&D activities during the cumulative first quarter.」
¥84.674 million was recorded as R&D expenses, with no significant changes in the status of R&D activities. - FY2021RestatedAnnual report
「The Company's basic policy is to put customers first. To respond to the rapidly changing market environment, it appropriately anticipates consumer needs and works to develop higher-value-added products and improve quality. R&D expenses for the Western-Style Confectionery Manufacturing and Sales Business for the fiscal year were ¥366.557 million.」
The disclosure covers product development and quality improvement based on customer needs, as well as R&D expenses, reaffirming the continuation of R&D activities. - FY2021-Q3RestatedAnnual report
「The amount spent on R&D activities during the cumulative third quarter was ¥279.531 million. There were no significant changes in the status of the Company's R&D activities during the cumulative third quarter.」
¥279.531 million was recorded as R&D expenses, with no significant changes in the status of R&D activities. - FY2021-Q2RestatedAnnual report
「The amount spent on R&D activities during the cumulative second quarter was ¥194.809 million. There were no significant changes in the status of the Company's R&D activities during the cumulative second quarter.」
¥194.809 million was recorded as R&D expenses, with no significant changes in the status of R&D activities. - FY2021-Q1RestatedAnnual report
「Research and development expenditure for the first quarter was ¥88.231 million. There were no material changes in the status of the company's research and development activities during the first quarter.」
R&D activities are continuing, with ¥88.231 million recorded as R&D expenses for the cumulative first quarter. There have been no significant changes in the status of these activities. - FY2020RestatedAnnual report
「The company's basic policy is to put customers first. To respond to the rapidly changing market environment, it works to accurately anticipate consumer needs, develop higher-value-added products and improve quality. Research and development expenditure for the Western-style confectionery manufacturing and sales business was ¥398.027 million for the fiscal year.」
The company reported product development and quality improvements based on customer needs, as well as research and development expenditure of ¥398.027 million, reaffirming the continuation of its research and development activities. - FY2020-Q3RestatedAnnual report
「Research and development expenditure for the first nine months was ¥301.253 million. There were no material changes in the status of the company's research and development activities during the first nine months.」
The company continued its research and development activities and recorded research and development expenditure of ¥301.253 million for the first nine months. It stated that there were no material changes in the status of these activities. - FY2020-Q2RestatedAnnual report
「Research and development expenditure for the first six months was ¥208.061 million. There were no material changes in the status of the company's research and development activities during the first six months.」
The company continued its research and development activities and recorded research and development expenditure of ¥208.061 million for the first six months. It stated that there were no material changes in the status of these activities. - FY2020-Q1RestatedAnnual report
「Research and development expenditure for the first quarter was ¥89.913 million. There were no material changes in the status of the company's research and development activities during the first quarter.」
The company continued its research and development activities and reported research and development expenditure of ¥89.913 million for the first quarter. It stated that there were no material changes in the status of these activities. - FY2019-Q3RestatedAnnual report
「Research and development expenditure for the first nine months was ¥305.852 million. There were no material changes in the status of the company's research and development activities during the first nine months.」
The company continued its research and development activities and recorded research and development expenditure of ¥305.852 million for the first nine months. It stated that there were no material changes in the status of these activities. - FY2019-Q2RestatedAnnual report
「Research and development expenditure for the first six months was ¥207.548 million. There were no material changes in the status of the company's research and development activities during the first six months.」
The company continued its research and development activities and recorded research and development expenditure of ¥207.548 million for the first six months. It stated that there were no material changes in the status of these activities. - FY2019-Q1RestatedAnnual report
「Research and development expenditure for the first quarter was ¥89.564 million. There were no material changes in the status of the company's research and development activities during the first quarter.」
The company continued its research and development activities and reported expenditure of ¥89.564 million for the first quarter. It stated that there were no material changes in the status of these activities. - FY2018RestatedAnnual report
「The company's basic policy is to put customers first. To respond to the rapidly changing market environment, it works to accurately anticipate consumer needs, develop higher-value-added products and improve quality. Research and development expenditure for the Western-style confectionery manufacturing and sales business was ¥399.093 million for the fiscal year.」
The company reported product development and quality improvements based on customer needs, as well as research and development expenditure of ¥399.093 million, with no material change in the continuation of its research and development activities. - FY2018-Q3RestatedAnnual report
「Research and development expenditure for the first nine months was ¥300.644 million. There were no material changes in the status of the company's research and development activities during the first nine months.」
The company continued its research and development activities and reported research and development expenditure of ¥300.644 million for the first nine months. It stated that there were no material changes in the status of these activities. - FY2018-Q2RestatedAnnual report
「Research and development expenditure for the first six months was ¥205.569 million. There were no material changes in the status of the company's research and development activities during the first six months.」
The company continued its research and development activities and reported research and development expenditure of ¥205.569 million for the first six months. It stated that there were no material changes in the status of these activities. - FY2018-Q1RestatedAnnual report
「Research and development expenditure for the first quarter was ¥87.488 million. There were no material changes in the status of the company's research and development activities during the first quarter.」
The company continued its research and development activities and reported expenditure of ¥87.488 million for the first quarter. It stated that there were no material changes in the status of these activities. - FY2017RestatedAnnual report
「Research and development expenditure for the Western-style confectionery manufacturing and sales business was ¥402.936 million for the fiscal year.」
The company continued its research and development activities and recorded research and development expenditure of ¥402.936 million for the fiscal year. It described activities including product development, brand development and customer communications using its website and social media, but there was no material change in the continued nature of these activities. - FY2017-Q3RestatedAnnual report
「Research and development expenditure for the first nine months was ¥303.477 million. There were no material changes in the status of the company's research and development activities during the first nine months.」
The company continued its research and development activities and reported expenditure of ¥303.477 million for the first nine months. It stated that there were no material changes in the status of these activities. - FY2017-Q2RestatedAnnual report
「Research and development expenditure for the first six months was ¥205.707 million. There were no material changes in the status of the company's research and development activities during the first six months.」
The company continued its research and development activities and reported expenditure of ¥205.707 million for the first six months. It stated that there were no material changes in the status of these activities. - FY2017-Q1First statedAnnual report
「Research and development expenditure for the first quarter was ¥86.358 million.」
Research and development expenditure of ¥86.358 million was recorded for the quarter.